Back to search

Article

Prevalence of RAF1 Aberrations in Metastatic Cancer Patients: A Real World Data

2023-09-29

Abstract excerpt

<h4>Purpose: </h4> Therapeutic targeting of RAF1 is promising, but it requires further investigation for the relation between clinical features and RAF1 aberrations regarding the MAPK signaling pathway in various solid tumors to realize the precision medicine. <h4>Methods:</h4> Between October 2019 and June 2023, Samsung Medical Center, 3,895 patients with metastatic cancer patients received a next-generation sequ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e3dabfe8-26c3-5eb2-9298-b7a686149c3e
DOI
10.20944/preprints202309.2074.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prevalence of RAF1 Aberrations in Metastatic Cancer Patients: A Real World DataDOI 10.20944/preprints202309.2074.v1
Prevalence of KRAS amplification in patients with metastatic cancer: Real-world next-generation sequencing analysis.Semantic proximity
Real-world genomic landscape of FGFR2 amplifications and fusions in solid tumors: analysis of 4,953 patients using clinical-grade NGSSemantic proximity
Spectrum of BRAF Aberrations and Its Potential Clinical Implications: Insights From Integrative Pan-Cancer AnalysisSemantic proximity
Unraveling BRAF alterations: molecular insights to circumvent therapeutic resistance across cancer typesSemantic proximity
The clinical, genomic, and transcriptomic landscape of BRAF mutant cancersSemantic proximity
Exploring Molecular Genetic Alterations and RAF Fusions in Melanoma: A Belvarafenib Expanded Access Program in Patients with RAS/RAF-Mutant Melanoma.Semantic proximity
Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial.Semantic proximity
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma.Semantic proximity
The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing.Semantic proximity
B-Raf mutation: a key player in molecular biology of cancer.Semantic proximity
BRAF: A Two-Faced Janus.Semantic proximity
Sequencing analysis of BRAF mutations in human cancers.Semantic proximity
Select a neighboring publication to make it the new centre.